Table 4. Treatment administered to children with severe pandemic (H1N1) 2009, Germany, 2009–2010*.
| Treatment |
Total |
Nonsurvivors not in PICU |
Admitted to PICU |
| Survivors | Nonsurvivors | Subtotal | p value | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
| Oseltamivir | 53/88 (60) | 2/4 (50) | 44/74 (59) | 7/10 (70) | 51/84 (61) | 0.733 | 1.6 (0.3–10.2) |
| Antimicrobial drug | 80/91 (88) | 4/4 (100) | 67/77 (87) | 9/10 (90) | 76/87 (87) | 1 | 1.3 (0.2–64.7) |
| Catecholamine | 28/85 (33) | 0/4 (0) | 20/70 (29) | 8/11 (73) | 28/81 (35) | 0.007 | 6.7 (1.4–41.8) |
| Mechanical ventilation | 56/90 (62) | 0/4 (0) | 45/75 (60) | 11/11 (100) | 56/86 (65) | 0.007 | NA (1.8–NA) |
*Values are no. positive/no with available information (%) except as indicated. PICU, pediatric intensive care unit; OR, odds ratio; CI, confidence interval, NA, not applicable.